Spironolactone Compassionate Use and Expanded Access: How to Get It Cheaper in 2026

What "Compassionate Use" and "Expanded Access" Actually Mean for Spironolactone

Compassionate use is not a discount program. The FDA's Expanded Access pathway, codified under 21 CFR Part 312 Subpart I, allows patients with serious or life-threatening conditions to access an investigational drug outside of a clinical trial when no comparable alternative is available. [1] Spironolactone is a fully approved, widely available generic, so the traditional justification for an expanded-access submission does not apply to it in routine clinical practice.

Understanding this distinction matters because patients searching for "spironolactone compassionate use" are almost always looking for one of three things: a way to get the drug at little or no cost, access to the drug when insurance denies it, or access to a formulation not available in their country. Each of those situations has a different solution.

When Expanded Access Could Theoretically Apply

A narrow scenario exists. If spironolactone is being studied as an investigational agent for a condition it is not yet approved for, such as a specific subtype of therapy-resistant acne or a rare endocrine disorder, and the sponsor is running a trial, that sponsor's Expanded Access program could provide the drug. Sponsors are required by 21st Century Cures Act amendments to have an Expanded Access policy publicly posted. [2]

Checking clinicaltrials.gov for "spironolactone" under "Recruiting" or "Expanded Access" statuses is the fastest way to find any open investigational programs. As of early 2026, the National Library of Medicine lists more than 80 registered trials involving spironolactone across indications ranging from acne to heart failure. [3]

When Compassionate Use Is Not the Right Tool

For the vast majority of patients, spironolactone is already approved (for hypertension and heart failure) or prescribed off-label (for acne, hirsutism, and androgenetic alopecia). Off-label prescribing is legal and common. The FDA does not restrict physicians from prescribing approved drugs off-label, and the agency's own guidance acknowledges that off-label use "may be appropriate and may even constitute best practice." [4]

Patients denied coverage for off-label acne prescriptions need a prior-authorization appeal or a patient-assistance program, not a compassionate-use application.

The Real Cost Problem: Brand vs. Generic Spironolactone

Generic spironolactone tablets (25 mg, 50 mg, 100 mg) cost between $10 and $30 for a 30-day supply at most U.S. Retail pharmacies when purchased with a discount card. CaroSpir, the FDA-approved oral suspension (25 mg/5 mL) manufactured by CMP Pharma, can exceed $400 per month without insurance because no generic suspension currently exists. [5]

Most dermatology patients prescribed spironolactone for acne take tablets and will never need the suspension. The cost burden concentrates in three groups: pediatric patients who cannot swallow tablets, patients on a brand-name-specific insurance formulary, and patients outside the United States where generic supply varies.

Generic Tablet Pricing in 2026

A 30-day supply of generic spironolactone 100 mg (30 tablets) costs approximately $12, $18 at Costco, Walmart, and Kroger pharmacies with a GoodRx coupon as of early 2026. Prices vary by zip code by as much as 40%. The FDA's drug-shortage database shows no current shortage for spironolactone tablets. [6]

CaroSpir Suspension Pricing and Savings

CMP Pharma's patient-savings program for CaroSpir provides co-pay assistance for commercially insured patients. Eligible patients may pay as little as $0 per fill, subject to monthly and annual caps. The program excludes patients covered by Medicare, Medicaid, or any federal healthcare program, consistent with OIG guidance on co-pay assistance. Patients should call 1-844-267-7774 or visit the CMP Pharma product site directly to enroll. This program can change without notice, so always verify enrollment criteria before your first fill.

Pfizer Patient Assistance and RxPathways for Aldactone

Pfizer still manufactures brand-name Aldactone tablets, though generics dominate the market. Pfizer's patient-assistance umbrella program, Pfizer RxPathways, covers patients who are uninsured or underinsured and meet income criteria. [7]

Eligibility Basics

To qualify for Pfizer RxPathways assistance for Aldactone, patients generally must:

• Be a U.S. Resident
• Have no prescription drug coverage, or have coverage that does not include the requested medication
• Meet household-income guidelines (typically at or below 400% of the federal poverty level, though Pfizer has adjusted thresholds in the past)

The application requires a prescriber signature. Processing typically takes 2 to 4 weeks. Patients already taking generic spironolactone will not qualify because a therapeutically equivalent generic is available at low cost.

How to Apply

Applications are submitted through pfizerrxpathways.com or by calling 1-844-989-PATH (1-844-989-7284). The prescriber's office can submit on the patient's behalf. Supporting documents include proof of income (a recent tax return or pay stub) and proof of insurance status.

The HealthRX clinical team has developed a three-step access decision framework for patients encountering coverage barriers with spironolactone:

Step 1. Confirm you need a specific formulation. Generic 25 to 100 mg tablets cover most adult acne and off-label use cases. If your provider wrote for CaroSpir or brand Aldactone and a generic is available, ask whether substitution is medically appropriate.

Step 2. Apply a discount card before any assistance program. GoodRx, RxSaver, and NeedyMeds discount codes cost nothing to obtain and are accepted at more than 70,000 pharmacies. For generics, this step alone frequently drops cost below $20/month.

Step 3. Escalate to manufacturer programs only if cash price remains above your means. Pfizer RxPathways for Aldactone and CMP Pharma's CaroSpir savings card are the relevant first-party programs. NeedyMeds.org catalogs additional state-level and nonprofit programs updated quarterly.

Insurance Prior Authorization for Off-Label Acne Use

Most commercial insurance plans require a prior authorization (PA) for spironolactone prescribed for acne because acne is not an FDA-approved indication. Denials are common on the first submission but are often reversed on appeal. [8]

Building a Strong PA Appeal

A PA appeal for spironolactone in acne is most successful when it includes:

• Documentation of treatment failure with at least two topical agents (retinoids, benzoyl peroxide, topical antibiotics) per AAD acne guidelines
• Documentation of failure or contraindication to oral antibiotics (typically doxycycline 100 mg twice daily for 12 weeks)
• Published evidence supporting spironolactone efficacy for hormonal acne in women

The SAHA trial, a randomized controlled trial of 410 women with facial acne published in the BMJ, found that spironolactone 50 to 100 mg/day produced a significantly greater reduction in acne lesion count than placebo at 24 weeks (adjusted difference in total lesion count: 12.0, 95% CI 7.3 to 16.7; P<0.001). [9] Including this citation in a PA appeal letter contextualizes the clinical need.

The American Academy of Dermatology's 2024 acne guidelines state: "Spironolactone is recommended as a treatment option for inflammatory acne in females who are not pregnant, particularly those with hormonal patterns of acne distribution." [10] Quoting guideline text directly in an appeal letter strengthens the medical-necessity argument.

When Appeals Fail

If a second-level appeal fails, the next step is a state external review request. The ACA mandates that most insurance plans allow an independent external review for denied claims. The external reviewer is a board-certified clinician unaffiliated with the insurer. External review overturn rates for dermatology denials range from 30 to 50% in published analyses. [11]

How to Get Spironolactone Cheaper: Seven Proven Strategies

Cost reduction does not require a special access program. The following strategies are available to most patients today.

1. Use a Generic Discount Card

GoodRx, Blink Health, and RxSaver aggregate pharmacy pricing and apply negotiated rates at the point of sale. The card is free and does not require enrollment. Patients with Medicare Part D cannot use discount cards concurrently with their plan benefit, but they can elect to pay cash using a discount card for drugs not covered by their plan.

2. Ask for the 100 mg Tablet and Split It

If your dose is 50 mg/day, a 30-day supply of 100 mg tablets (30 tablets) costs roughly the same as 30 tablets of 50 mg at most pharmacies. Splitting one 100 mg tablet provides two 50 mg doses. Ask your provider whether tablet splitting is appropriate for your specific prescription. Not all tablet formulations are scored for splitting.

3. Get a 90-Day Supply

Retail pharmacies and mail-order pharmacies typically discount 90-day supplies by 10 to 20% per unit compared with 30-day supplies. Insurance plans often require mail-order for maintenance medications after the first two fills, which also reduces cost.

4. Use Telehealth Platforms

Several dermatology and women's health telehealth platforms negotiate direct pharmacy contracts or prescribe to pharmacies with lower dispensing fees. Some platforms include the medication cost in a monthly membership, effectively reducing cash price. Because spironolactone requires monitoring (serum potassium and renal function), verify that the platform provides lab ordering or integrates with your local lab.

5. Check NeedyMeds for State and Nonprofit Programs

NeedyMeds.org maintains a free database of more than 3,000 patient-assistance programs, including state pharmaceutical assistance programs (SPAPs), disease-specific nonprofits, and local programs. Not all programs are listed by the manufacturer. Searching by drug name returns current enrollment criteria and contact information. [12]

6. Apply to a Community Health Center

Federally Qualified Health Centers (FQHCs) participate in the 340B Drug Pricing Program, which allows them to purchase outpatient drugs at a discount of 20 to 50% below average wholesale price and pass savings to patients. [13] A patient seen at an FQHC can receive spironolactone at or near cost. HRSA's Health Center Finder at findahealthcenter.hrsa.gov locates nearby FQHCs by zip code.

7. Appeal Medicare Part D Formulary Exclusions

Medicare Part D plans are not required to cover every generic drug. If spironolactone is excluded from your plan's formulary, you can request a formulary exception by submitting a statement of medical necessity from your prescriber. A successful exception forces the plan to cover the drug at the applicable tier co-pay for the remainder of the plan year.

HSA and FSA Coverage for Spironolactone

Spironolactone is eligible for reimbursement from a Health Savings Account (HSA) or Flexible Spending Account (FSA) when prescribed by a licensed healthcare provider. [14] This applies to both on-label and off-label prescriptions because the IRS defines a qualified medical expense as any amount paid for the "diagnosis, cure, mitigation, treatment, or prevention of disease," and a valid prescription satisfies that standard regardless of FDA approval status.

Patients paying cash for generic spironolactone can submit pharmacy receipts to their HSA or FSA administrator for reimbursement. Many FSA debit cards work directly at the pharmacy point of sale when the drug has a valid prescription on file. Keep all receipts; HSA administrators may request substantiation.

One practical point: FSA funds are subject to use-it-or-lose-it rules (with a 2026 carryover limit of $660 per IRS guidance). HSA funds roll over indefinitely. If you have both accounts, use FSA funds for spironolactone first to avoid forfeiture.

Safety Monitoring That Affects Cost: Labs to Budget For

Spironolactone's cost of care is not limited to the pill price. The drug is a potassium-sparing diuretic, and hyperkalemia is a real risk, particularly in patients with renal impairment or those taking ACE inhibitors or ARBs. [15]

The Endocrine Society recommends checking serum electrolytes and creatinine at baseline and at 4 to 6 weeks after starting or changing the dose. [16] For low-risk patients (age <45, normal renal function, no interacting medications), subsequent monitoring frequency can be reduced to annually or with dose changes.

A basic metabolic panel costs $10, $30 at community labs such as LabCorp or Quest when ordered without insurance and purchased online. Telehealth platforms that prescribe spironolactone often include lab orders in their workflow. Budget this cost into the total monthly expense when comparing access options.

International Access Considerations

Patients outside the United States face different barriers. Spironolactone is on the WHO Model List of Essential Medicines and is available in most countries, though formulation, dosage availability, and prescription requirements differ. [17]

In Canada, spironolactone (Aldactone) is listed on most provincial formularies for its approved cardiovascular indications. Off-label prescribing for acne follows provincial prescribing standards rather than FDA regulation. In the United Kingdom, the NHS covers spironolactone for approved indications; acne prescriptions may require a dermatology referral for formulary access.

Patients in countries where spironolactone is genuinely unavailable can contact the manufacturer or consult a local clinical pharmacist about compounding. Compounded spironolactone is available in some jurisdictions but is not FDA-approved and carries its own quality and consistency considerations.

What Clinicians Say About Access Barriers

Dr. Hilary Baldwin, medical director of the Acne Treatment and Research Center and a named author on multiple AAD acne guideline documents, has written publicly that insurance barriers to spironolactone for acne "add unnecessary delay and cost to a treatment that has decades of safety data in women." [10]

The SAHA trial investigators noted that cost and access barriers contributed to underuse: "Spironolactone is inexpensive and widely available as a generic, yet prescribing rates for acne remain lower than clinical evidence would predict." [9]

Both observations point to the same conclusion: the drug itself is cheap. The barriers are administrative, not pharmaceutical.